Ausgabe 3/2020
Inhalt (14 Artikel)
The role of ErbB4 in cancer
Vincent F.M. Segers, Lindsey Dugaucquier, Eline Feyen, Hadis Shakeri, Gilles W. De Keulenaer
CXCL-10: a new candidate for melanoma therapy?
Hossein Bagheri, Mohammad Hossein Pourhanifeh, Maryam Derakhshan, Maryam Mahjoubin-Tehran, Faezeh Ghasemi, Shabnam Mousavi, Rouhollah Rafiei, Kazem Abbaszadeh-Goudarzi, Hamid Reza Mirzaei, Hamed Mirzaei
Insulinoma-associated protein 1 (INSM1): a potential biomarker and therapeutic target for neuroendocrine tumors
B. Mahalakshmi, Rathinasamy Baskaran, M. Shanmugavadivu, Ngoc Tuan Nguyen, Bharath Kumar Velmurugan
Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation
Jun Ma, Li-Na Han, Jian-Rui Song, Xiao-Ming Bai, Ju-Zi Wang, Li-Feng Meng, Jian Li, Wen Zhou, Yun Feng, Wei-Rong Feng, Jun-Jun Ma, Jun-Tao Hao, Zeng-Qiang Shen
FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer
Chunli Yin, Xiaoyan Lin, Yige Wang, Xianqiang Liu, Yi Xiao, Jingchao Liu, Antoine M Snijders, Guangwei Wei, Jian-Hua Mao, Pengju Zhang
Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer
Jie He, Hongli Huang, Yanlei Du, Dong Peng, Youlian Zhou, Yuyuan Li, Hong Wang, Yongjian Zhou, Yuqiang Nie
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms
Niclas C. Blessin, Patrick Spriestersbach, Wenchao Li, Tim Mandelkow, David Dum, Ronald Simon, Claudia Hube-Magg, Florian Lutz, Florian Viehweger, Maximillian Lennartz, Christoph Fraune, Vera Nickelsen, Wilfried Fehrle, Cosima Göbel, Sören Weidemann, Till Clauditz, Patrick Lebok, Katharina Möller, Stefan Steurer, Jacob R. Izbicki, Guido Sauter, Sarah Minner, Frank Jacobsen, Andreas M. Luebke, Franziska Büscheck, Doris Höflmayer, Waldemar Wilczak, Eike Burandt, Andrea Hinsch
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer
Leticia Serrano-Oviedo, Miriam Nuncia-Cantarero, Sara Morcillo-Garcia, Cristina Nieto-Jimenez, Miguel Burgos, Veronica Corrales-Sanchez, Javier Perez-Peña, Balázs Győrffy, Alberto Ocaña, Eva María Galán-Moya
Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer
Sandro Mascena Gomes-Filho, Edmilson Ozorio dos Santos, Ester Risério Matos Bertoldi, Luiza Coimbra Scalabrini, Vitor Heidrich, Bianca Dazzani, Elena Levantini, Eduardo Moraes Reis, Daniela Sanchez Bassères
Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma
Jinpeng Zhou, Yang Jiang, Junshuang Zhao, Haiying Zhang, Jinlong Fu, Peng Luo, Yanju Ma, Dan Zou, Huiling Gao, Jiangfeng Hu, Ye Zhang, Zhitao Jing
CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145
Han Yang, Mengjing Zhao, Lihao Zhao, Ping Li, Yuxia Duan, Gang Li
WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway
Baohua Li, Xuedong Guo, Na Li, Qin Chen, Junhua Shen, Xiaoxiu Huang, Genping Huang, Fenfen Wang
Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients
Parwez Ahmad, Marek Slavik, Karolina Trachtova, Natalia Anna Gablo, Tomas Kazda, Dominik Gurin, Pavel Smilek, Zuzana Horakova, Bretislav Gal, Marketa Hermanova, Pavel Slampa, Jiri Sana, Ondrej Slaby
Author Correction: The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
Lourdes Cortes-Dericks, Domenico Galetta